» Articles » PMID: 19775929

Glycomics and Disease Markers

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2009 Sep 25
PMID 19775929
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Glycomics is the comprehensive study of all glycans expressed in biological systems. The biosynthesis of glycan relies on a number of highly competitive processes involving glycosyl transferases. Glycosylation is therefore highly sensitive to the biochemical environment and has been implicated in many diseases including cancer. Recently, interest in profiling the glycome has increased owing to the potential of glycans for disease markers. In this regard, mass spectrometry is emerging as a powerful technique for profiling the glycome. Global glycan profiling of human serum based on mass spectrometry has already led to several potentially promising markers for several types of cancer and diseases.

Citing Articles

Nanopore-based glycan sequencing: state of the art and future prospects.

Yao G, Ke W, Xia B, Gao Z Chem Sci. 2024; 15(17):6229-6243.

PMID: 38699252 PMC: 11062086. DOI: 10.1039/d4sc01466a.


Influence of plasma collection tubes on N-glycome in human blood samples.

Zhang Z, Cui X, Zhou N, Zhu L, Zhi Y, Zhang S Pract Lab Med. 2024; 39:e00383.

PMID: 38463195 PMC: 10924059. DOI: 10.1016/j.plabm.2024.e00383.


N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm.

Nieminen H, Nummela P, Satomaa T, Heiskanen A, Hiltunen J, Kaprio T Sci Rep. 2023; 13(1):13191.

PMID: 37580349 PMC: 10425445. DOI: 10.1038/s41598-023-39220-4.


The -Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation.

Plavsa B, Szavits-Nossan J, Blivajs A, Rapcan B, Radovani B, Sesto I Biomolecules. 2023; 13(4).

PMID: 37189353 PMC: 10135591. DOI: 10.3390/biom13040605.


Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19.

Xie Y, Butler M Glycobiology. 2022; 32(10):871-885.

PMID: 35925863 PMC: 9487901. DOI: 10.1093/glycob/cwac051.


References
1.
Cooke C, An H, Kim J, Canfield D, Torres J, Lebrilla C . Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology. 2009; 137(3):1061-71, 1071.e1-8. DOI: 10.1053/j.gastro.2009.04.014. View

2.
Turnbull J, Field R . Emerging glycomics technologies. Nat Chem Biol. 2007; 3(2):74-7. DOI: 10.1038/nchembio0207-74. View

3.
Dennis J, Granovsky M, Warren C . Protein glycosylation in development and disease. Bioessays. 1999; 21(5):412-21. DOI: 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5. View

4.
Bereman M, Islam Williams T, Muddiman D . Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients. Anal Chem. 2008; 81(3):1130-6. PMC: 3739471. DOI: 10.1021/ac802262w. View

5.
Royle L, Campbell M, Radcliffe C, White D, Harvey D, Abrahams J . HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem. 2008; 376(1):1-12. DOI: 10.1016/j.ab.2007.12.012. View